AstraZeneca plans to invest $50 billion in US by 2030
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
Investment will support AstraZeneca’s ambition to reach $80 billion revenue by 2030, with 50% generated in the US
The new Zigly center features and offers comprehensive veterinary services
Aims to support healthcare practitioners with evidence-based cough categorization tools that enable choosing the right molecules for effective & targeted relief from cough
Baxdrostat demonstrated a statistically significant and clinically meaningful reduction of systolic blood pressure compared with placebo
This year, 40 women students are participating, selected through a rigorous process evaluating academic merit, research interest, and socio-economic background
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
The pharmaceuticals laboratory supports North Asia with formulation development, reverse engineering, troubleshooting, and analysis for various dosage forms
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
25 women students to receive internship, training, and mentorship in Life Sciences segment
Bisoprolol is a highly cardioselective beta-1 adrenergic blocker used to manage high blood pressure,
Subscribe To Our Newsletter & Stay Updated